SATB1 Expression Is Associated with Biologic Behavior in Colorectal Carcinoma In Vitro and In Vivo

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zhang, Jie ^a   Zhang, Baogang ^a   Zhang, Xumei ^a   Sun, Yingui ^a   Wei, Xiaolong ^b   McNutt, Michael A ^c   Lu, Shijun ^a   Liu, Yuqing ^a   Zhang, Donghong ^d   Wang, Mingyu ^a   Lin, Zhijuan ^a   Niu, Na ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; B RAF KINASE; BIOLOGICAL MARKER; CYCLIN D1; CYCLINE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; COLONY FORMATION; COLORECTAL CARCINOMA; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADULT; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MATRIX METALLOPROTEINASE 2; MICROSCOPY, CONFOCAL; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS B-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84872232273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047902     Document Type: Article

References (42)

1. Galande S, Purbey PK, Notani D, Kumar PP, (2007) The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. Curr Opin Genet Dev 17: 408-414.
2. Kouzarides T, (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9: 40-48.
3. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, et al. (2000) The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14: 521-535.
4. Pavan Kumar P, Purbey PK, Sinha CK, Notani D, Limaye A, et al. (2006) Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 22: 231-243.
5. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, et al. (2005) SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 105: 3330-3339.
6. Cai S, Lee CC, Kohwi-Shigematsu T, (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278-1288.
7. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T, (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193.
8. Cheng C, Lu X, Wang G, Zheng L, Shu X, et al. (2010) Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. Apmis 118: 855-863.
9. Zhao XD, Ji WY, Zhang W, He LX, Yang J, et al. (2011) Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 72: 1-5.
10. Chen H, Takahara M, Oba J, Xie L, Chiba T, et al. (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 64: 39-44.
11. Peng ZK, Yang DH, Li XH, Huang Y, Zhang GQ, et al. (2011) [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao 31: 1207-1211.
12. Zhao XL, Wang P, (2011) [Expression of SATB1 and BRMS1 in ovarian serous adenocarcinoma and its relationship with clinieopathological features]. Sichuan Da Xue Xue Bao Yi Xue Ban 42: 82-85.
13. Liu CX, Wen Y, Xu K, Zheng SB, Xu YW, et al. (2010) [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao 30: 1389-1391.
14. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, et al. (2012) Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis. 27: 143-50.
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
16. Markowitz SD, Dawson DM, Willis J, Willson JK, (2002) Focus on colon cancer. Cancer Cell 1: 233-236.
17. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O, (2004) Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 40: 1593-1598.
18. Niu N, Zhang J, Guo Y, Yang C, Gu J, (2009) Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic ganglia. Lab Invest 89: 636-644.
19. Niu N, Zhang J, Sun Y, Wang S, Sun Y, et al. (2011) Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye. Cell Mol Life Sci 68: 2481-2492.
20. Sun XF, Carstensen JM, Stal O, Zhang H, Nordenskjold B, (1996) Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma. Int J Cancer 69: 5-8.
21. Niu N, Zhang J, Guo Y, Zhao Y, Korteweg C, et al. (2011) Expression and distribution of immunoglobulin G and its receptors in the human nervous system. Int J Biochem Cell Biol 43: 556-563.
22. Levidou G, Saetta AA, Gigelou F, Karlou M, Papanastasiou P, et al. (2012) ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World J Surg Oncol 10: 47.
23. Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, et al. (2003) An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 63: 5073-5083.
24. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, et al. (2003) Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 63: 6488-6495.
25. Zheng H, Li M, Liu H, Ren W, Hu DS, et al. (2007) Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int 31: 82-87.
26. Webber MM, Waghray A, Bello D, (1995) Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1: 1089-1094.
27. Nie H, Yao X, Maika SD, Tucker PW, (2008) SATB1 is required for CD8 coreceptor reversal. Mol Immunol 46: 207-211.
28. Debska S, Kubicka J, Czyzykowski R, Habib M, Potemski P, (2012) [PARP inhibitors-theoretical basis and clinical application]. Postepy Hig Med Dosw (Online) 66: 311-321.
29. Rigakos G, Razis E, (2012) BRCAness: Finding the Achilles Heel in Ovarian Cancer. Oncologist 17: 956-962.
30. Forma E, Wojcik-Krowiranda K, Bienkiewicz A, Brys M, (2012) [Molecular basis of gynecological oncology-TopBP1 protein and its participation in the transcription process]. Ginekol Pol 83: 363-367.
31. Stecklein SR, Jensen RA, (2012) Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology. Transl Res. 160: 178-197.
32. Fernandez SV, Huang Y, Snider KE, Zhou Y, Pogash TJ, et al. (2012) Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol 41: 369-377.
33. Markowitz SD, Bertagnolli MM, (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460.
34. Ahnen DJ, (2011) The American College of Gastroenterology Emily Couric Lecture-the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived? Am J Gastroenterol 106: 190-198.
35. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, et al. (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137-1144.
36. Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, et al. (2008) BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 8: 255.
37. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB, (2012) Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet 49: 151-157.
38. Zlobec I, Lugli A, (2008) Prognostic and predictive factors in colorectal cancer. Postgrad Med J 84: 403-411.
39. Ioachim E, (2008) Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Int J Clin Pract 62: 1736-1743.
40. Turnbull CL, Bacon AL, Dunlop MG, Farrington SM, (2012) In vitro stability of APC gene sequences and the influence of DNA repair status. Mutagenesis 27: 233-238.
41. Laulier C, Lopez BS (2012) The secret life of Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2 family members. Mutat Res: Epub ahead of print.
42. Tanikawa C, Nakagawa H, Furukawa Y, Nakamura Y, Matsuda K, (2012) CLCA2 as a p53-inducible senescence mediator. Neoplasia 14: 141-149.